GSK "FAKEL", Tatarstan, Republic

Accounting reports

Previously








Share:
Name
Kooperativ PO STROITEL'STVU I EKSPLUATATSII GARAZHEY "FAKEL"
INN
1660020260
KPP
166001001
OGRN
1031630200403
OKPO
40682417
Address
420088, RESPUBLIKA TATARSTAN (TATARSTAN), Kazan', ul. Zur uram, d. 6A
Phone
+7 (917) 249-48-55  Contact details

Extract from EGRUL $12 (€10)

Last name, first name & patronymic of the General Director

List of founders

Position of the company

Licenses

Authorized capital

Branches

Complete structure of the extract
We guarantee to provide you with an actual
information extract

Data on types of economic activities
GSK "FAKEL" according to EGRUL

OKVED codeTypeName of activity type
52.21.24Core activity Activities of Parking for vehicles
Registration date
05.01.2003
Registering department
MEZHRAYONNAYA IFNS ROSSII N6 PO RESPUBLIKE TATARSTAN

GSK "FAKEL" (Tatarstan, Republic; INN 1660020260) was registered on 5 Jan 2003. Type of ownership of GSK "FAKEL" - Comsumer cooperatives.

Form of ownership of GSK "FAKEL" - Private property.

Principal activities of GSK "FAKEL": activities of parking for vehicles (52.21.24).

Economic indicators

2023

Net profit (RAS) of GSK FAKEL dropped in 2023 2.00 times to 6.00 thousand RUB from 12.00 thousand RUB over the same period in 2022, the company informed.

Revenue decreased in the accounting period by 33.93% to 409.00 thousand RUB from 619.00 thousand RUB in 2022; cost of goods sold decreased by 33.28% to 391.00 thousand RUB from 586.00 thousand RUB; sales profit fell by 45.45% to 18.00 thousand RUB from 33.00 thousand RUB.

2022

Net profit (RAS) of GSK FAKEL grew over 2022 6.00 times to 12.00 thousand RUB from 2.00 thousand RUB over 2021, the company informed.

Revenue increased in the accounting period by 23.80% to 619.00 thousand RUB from 500.00 thousand RUB over 2021; cost of goods sold grew by 21.83% to 586.00 thousand RUB from 481.00 thousand RUB; sales profit went up 1.74 times to 33.00 thousand RUB from 19.00 thousand RUB.

2021

Net profit (RAS) of GSK FAKEL made up 2.00 thousand RUB over 2021 compared to net loss of 5.00 thousand RUB over 2020, the company informed.

Revenue increased in the accounting period by 1.21% to 500.00 thousand RUB from 494.00 thousand RUB over 2020; cost of goods sold decreased by 1.64% to 481.00 thousand RUB from 489.00 thousand RUB; sales profit went up 3.80 times to 19.00 thousand RUB from 5.00 thousand RUB.

2020

Net loss (RAS) of GSK FAKEL dropped over 2020 by 28.57% to 5.00 thousand RUB from 7.00 thousand RUB KAgent.Entities.Balance, the company informed.

Revenue decreased in the accounting period by 2.76% to 494.00 thousand RUB from 508.00 thousand RUB in 2019; cost of goods sold decreased by 2.00% to 489.00 thousand RUB from 499.00 thousand RUB; sales profit fell by 44.44% to 5.00 thousand RUB from 9.00 thousand RUB.

2019

Net loss (RA) of GSK FAKEL made up 7.00 thousand RUB over 2019 compared to net profit of 20.00 thousand RUB over 2018, the company informed.

Revenue increased in the accounting period by 9.25% to 508.00 thousand RUB from 465.00 thousand RUB over 2018; cost of goods sold grew by 13.93% to 499.00 thousand RUB from 438.00 thousand RUB; sales profit fell 3.00 times to 9.00 thousand RUB from 27.00 thousand RUB.

2018

Net profit (RAS) of GSK FAKEL dropped in 2018 2.40 times to 20.00 thousand RUB from 48.00 thousand RUB over the same period in 2017, the company informed.

Revenue decreased in the accounting period by 19.83% to 465.00 thousand RUB from 580.00 thousand RUB in 2017; cost of goods sold decreased by 17.05% to 438.00 thousand RUB from 528.00 thousand RUB; sales profit fell by 48.08% to 27.00 thousand RUB from 52.00 thousand RUB.

2017

Net profit (RAS) of GSK FAKEL made up 48.00 thousand RUB over 2017 compared to net loss of 40.00 thousand RUB over 2016, the company informed.

Revenue increased in the accounting period by 16.23% to 580.00 thousand RUB from 499.00 thousand RUB over 2016; cost of goods sold decreased by 1.49% to 528.00 thousand RUB from 536.00 thousand RUB; sales profit made up 52.00 thousand RUB compared to sales loss of 37.00 thousand RUB.

2016

Net loss (RAS) of GSK FAKEL dropped over 2016 2.50 times to 40.00 thousand RUB from 100.00 thousand RUB KAgent.Entities.Balance, the company informed.

Revenue increased in the accounting period by 6.62% to 499.00 thousand RUB from 468.00 thousand RUB over 2015; cost of goods sold decreased by 5.63% to 536.00 thousand RUB from 568.00 thousand RUB; sales loss decreased 2.70 times to 37.00 thousand RUB from 100.00 thousand RUB.

2014

Net profit (RAS) of GSK Fakel dropped in 2014 5.80 times to 10.00 thousand RUB from 58.00 thousand RUB over the same period in 2013, the company informed.

Revenue decreased in the accounting period by 2.33% to 502.00 thousand RUB from 514.00 thousand RUB in 2013; cost of goods sold grew by 7.89% to 492.00 thousand RUB from 456.00 thousand RUB; sales profit fell 5.80 times to 10.00 thousand RUB from 58.00 thousand RUB.

2013

Net profit (RAS) of GSK Fakel made up 58.00 thousand RUB over 2013 compared to net loss of 59.00 thousand RUB over 2012, the company informed.

Revenue increased in the accounting period by 21.80% to 514.00 thousand RUB from 422.00 thousand RUB over 2012; cost of goods sold decreased by 5.20% to 456.00 thousand RUB from 481.00 thousand RUB; sales profit made up 58.00 thousand RUB compared to sales loss of 59.00 thousand RUB.




Daily subscription $39 (€32)

unlimited access to database "Kontragent"

download any information within 24 hours

Companies in the region

Guarantees

Guarantees
We guarantee
provision of
relevant
information

Payment methods


Statistics
Companies
12 288 098
Reports
17 430 711
Rrocessed requests
Extract from EGRUL:
Today, 9:20 PM
Accounting reports:
Today, 9:21 PM
The site can contain materials of 16+ category
+7(495) 729−17−96,    info@k-agent.ru
Рейтинг@Mail.ru © "Info-RL", 2006—2024
About the project    Legal basis
Business Business Services Others Info-RL, ООО
Moscow ul. Kazakova, d. 3, str. 4 105064
+7(495) 729−17−96 7 days a week info@k-agent.ru